Observational studyClinical and experimental medicine2024

Safety of Janus kinase inhibitors compared to biological DMARDs in patients with rheumatoid arthritis and renal impairment: the ANSWER cohort study.

Yoichi Nakayama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.